MedPath
NMPA Approval

Dasabuvir Sodium Tablets

H20181130

March 2, 2018

H20170367

Drug Information

达塞布韦钠片

易奇瑞

片剂

化学药品

March 2, 2018

September 19, 2022

Company Information

Applicant Company

Maidenhead SL6 4UB,United Kingdom

Manufacturing Company

Manorhamilton Road, Sligo, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达塞布韦钠片 - NMPA 批准文号 | MedPath